ArticleVaccines2024

Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?

Haozhe Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.